Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Edward Neuwelt
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Physiology
Disorders
Living Beings
Anatomy
Chemicals & Drugs
Concepts & Ideas
Procedures
Phenomena
Sign-in to see full Profile
Network (preview)
43
Muldoon, Leslie
29
Doolittle, Nancy
19
Pagel, Michael
18
Roman-Goldstein, SM
17
McCormick, CI
15
Jahnke, Kristoph
14
Kroll, RA
11
Abrey, Lauren
11
Remsen, LG
10
Kraemer, Dale
7
Fortin, David
6
Peereboom, David
6
Peterson, Darryl
6
Rapoport, Stanley
6
Shenkier, Tamara
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Edward Neuwelt (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Neuwelt Alexander J; Wu Y Jeffrey; Knap Narcyz; Losin Marcin; Neuwelt Edward A; Pagel Michael A; Warmann Steven; Fuchs Joerg; Czauderna Piotr; Wozniak Michal
Using acetaminophen's toxicity mechanism to enhance cisplatin efficacy in hepatocarcinoma and hepatoblastoma cell lines.
Neoplasia (New York, N.Y.) 2009;11(10):1003-11.
-
2009: Jahnke Kristoph; Muldoon Leslie L; Varallyay Csanad G; Lewin Seth J; Brown Robert D; Kraemer Dale F; Soussain Carole; Neuwelt Edward A
Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.
Neuro-oncology 2009;11(5):503-13.
-
2009: Angelov Lilyana; Doolittle Nancy D; Kraemer Dale F; Siegal Tali; Barnett Gene H; Peereboom David M; Stevens Glen; McGregor John; Jahnke Kristoph; Lacy Cynthia A; Hedrick Nancy A; Shalom Edna; Ference Sandra; Bell Susan; Sorenson Lisa; Tyson Rose Marie; Haluska Marianne; Neuwelt Edward A
Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(21):3503-9.
-
2009: Tritz Richard; Hickey Michelle J; Lin Amy H; Hadwiger Philipp; Sah Dinah W Y; Neuwelt Edward A; Mueller Barbara M; Kruse Carol A
FAPP2 gene downregulation increases tumor cell sensitivity to Fas-induced apoptosis.
Biochemical and biophysical research communications 2009;383(2):167-71.
-
2009: Varallyay Csanad G; Muldoon Leslie L; Gahramanov Seymur; Wu Yingjen J; Goodman James A; Li Xin; Pike Martin M; Neuwelt Edward A
Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2009;29(4):853-60.
-
2009: Jahnke Kristoph; Muldoon Leslie L; Varallyay Csanad G; Lewin Seth J; Kraemer Dale F; Neuwelt Edward A
Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model.
Neuro-oncology 2009;11(2):142-50.
-
2009: Neuwelt Edward A; Hamilton Bronwyn E; Varallyay Csanad G; Rooney William R; Edelman Robert D; Jacobs Paula M; Watnick Suzanne G
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Kidney international 2009;75(5):465-74.
-
2009: Wu Yingjen Jeffrey; Muldoon Leslie L; Dickey Dana Thomas; Lewin Seth J; Varallyay Csanad G; Neuwelt Edward A
Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models.
Neoplasia (New York, N.Y.) 2009;11(2):187-95.
-
2008: Grimm S A; McCannel C A; Omuro A M P; Ferreri A J M; Blay J-Y; Neuwelt E A; Siegal T; Batchelor T; Jahnke K; Shenkier T N; Hall A J; Graus F; Herrlinger U; Schiff D; Raizer J; Rubenstein J; Laperriere N; Thiel E; Doolittle N; Iwamoto F M; Abrey L E
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
Neurology 2008;71(17):1355-60.
-
2008: Dickey D Thomas; Muldoon Leslie L; Doolittle Nancy D; Peterson Darryl R; Kraemer Dale F; Neuwelt Edward A
Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models.
Cancer chemotherapy and pharmacology 2008;62(2):235-41.
-
2008: Stenstrom David A; Muldoon Leslie L; Armijo-Medina Hector; Watnick Suzanne; Doolittle Nancy D; Kaufman John A; Peterson Darryl R; Bubalo Joseph; Neuwelt Edward A
N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
Journal of vascular and interventional radiology : JVIR 2008;19(3):309-18.
-
2008: Smith J R; Henderson W W; Rosenbaum J T; Neuwelt E A; Moses A V
Cultured human endothelial cells expressing HIV-1 Vpu and Tat support the expansion of malignant B cells from primary central nervous system lymphoma.
The British journal of ophthalmology 2008;92(2):297-9.
-
2008: Jahnke Kristoph; Kraemer Dale F; Knight Kristin R; Fortin David; Bell Susan; Doolittle Nancy D; Muldoon Leslie L; Neuwelt Edward A
Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
Cancer 2008;112(3):581-8.
-
2008: Doolittle Nancy D; Abrey Lauren E; Shenkier Tamara N; Tali Siegal; Bromberg Jacoline E C; Neuwelt Edward A; Soussain Carole; Jahnke Kristoph; Johnston Patrick; Illerhaus Gerald; Schiff David; Batchelor Tracy; Montoto Silvia; Kraemer Dale F; Zucca Emanuele
Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report.
Blood 2008;111(3):1085-93.
-
2008: Harned Theresa M; Kalous Ondrej; Neuwelt Alexander; Loera Jason; Ji Lingyun; Iovine Peter; Sposto Richard; Neuwelt Edward A; Reynolds C Patrick
Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(2):533-40.
-
2008: Neuwelt Edward; Abbott N Joan; Abrey Lauren; Banks William A; Blakley Brian; Davis Thomas; Engelhardt Britta; Grammas Paula; Nedergaard Maiken; Nutt John; Pardridge William; Rosenberg Gary A; Smith Quentin; Drewes Lester R
Strategies to advance translational research into brain barriers.
Lancet neurology 2008;7(1):84-96.
-
2007: Wu Y Jeffrey; Muldoon Leslie L; Varallyay Csanad; Markwardt Sheila; Jones Richard E; Neuwelt Edward A
In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging.
American journal of physiology. Cell physiology 2007;293(5):C1698-708.
-
2007: Grimm S A; Pulido J S; Jahnke K; Schiff D; Hall A J; Shenkier T N; Siegal T; Doolittle N D; Batchelor T; Herrlinger U; Neuwelt E A; Laperriere N; Chamberlain M C; Blay J Y; Ferreri A J M; Omuro A M P; Thiel E; Abrey L E
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1851-5.
-
2007: Jahnke Kristoph; Thiel Eckhard; Abrey Lauren E; Neuwelt Edward A; Korfel Agnieszka
Diagnosis and management of primary intraocular lymphoma: an update.
Clinical ophthalmology (Auckland, N.Z.) 2007;1(3):247-58.
-
2007: Doolittle Nancy D; Jahnke Kristoph; Belanger Richard; Ryan Deborah A; Nance Robert W; Lacy Cynthia A; Tyson Rose Marie; Haluska Marianne; Hedrick Nancy A; Varallyay Csanad; Neuwelt Edward A
Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma.
Leukemia & lymphoma 2007;48(9):1712-20.
-
2007: Rosenbaum James T; Martin Tammy M; Farris Kendra H; Rosenbaum Richard B; Neuwelt Edward A
Can medical schools teach high school students to be scientists?
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(9):1954-7.
-
2007: Muldoon Leslie L; Soussain Carole; Jahnke Kristoph; Johanson Conrad; Siegal Tali; Smith Quentin R; Hall Walter A; Hynynen Kullervo; Senter Peter D; Peereboom David M; Neuwelt Edward A
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2295-305.
-
2007: Soussain Carole; Muldoon Leslie L; Varallyay Csanad; Jahnke Kristoph; DePaula Luciana; Neuwelt Edward A
Characterization and magnetic resonance imaging of a rat model of human B-cell central nervous system lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(8):2504-11.
-
2007: Neuwelt Edward A; Várallyay Csanád G; Manninger Sándor; Solymosi Diána; Haluska Marianne; Hunt Matthew A; Nesbit Gary; Stevens Alexander; Jerosch-Herold Michael; Jacobs Paula M; Hoffman John M
The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
Neurosurgery 2007;60(4):601-11; discussion 611-2.
-
2007: Knight Kristin R; Kraemer Dale F; Winter Christiane; Neuwelt Edward A
Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(10):1190-5.
-
2007: Doolittle Nancy D; Peereboom David M; Christoforidis Gregory A; Hall Walter A; Palmieri Diane; Brock Penelope R; Campbell Kathleen C M; Dickey D Thomas; Muldoon Leslie L; O'Neill Brian Patrick; Peterson Darryl R; Pollock Brad; Soussain Carole; Smith Quentin; Tyson Rose Marie; Neuwelt Edward A
Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting.
Journal of neuro-oncology 2007;81(1):81-91.
-
2006: Neuwelt Edward A; Gilmer-Knight Kristin; Lacy Cynthia; Nicholson H Stacy; Kraemer Dale F; Doolittle Nancy D; Hornig Gregory W; Muldoon Leslie L
Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
Pediatric blood & cancer 2006;47(2):174-82.
-
2006: Jahnke Kristoph; Korfel Agnieszka; O'Neill Brian Patrick; Blay Jean-Yves; Abrey Lauren E; Martus Peter; Poortmans Philip M P; Shenkier Tamara N; Batchelor Tracy T; Neuwelt Edward A; Raizer Jeffrey J; Schiff David; Pels Hendrik; Herrlinger Ulrich; Stein Harald; Thiel Eckhard
International study on low-grade primary central nervous system lymphoma.
Annals of neurology 2006;59(5):755-62.
-
2006: Hall Walter A; Doolittle Nancy D; Daman Megan; Bruns Patti K; Muldoon Leslie; Fortin David; Neuwelt Edward A
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.
Journal of neuro-oncology 2006;77(3):279-84.
-
2006: Muldoon L L; Tratnyek P G; Jacobs P M; Doolittle N D; Christoforidis G A; Frank J A; Lindau M; Lockman P R; Manninger S P; Qiang Y; Spence A M; Stupp S I; Zhang M; Neuwelt E A
Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.
AJNR. American journal of neuroradiology 2006;27(3):715-21.
-
2006: Hunt Matthew A; Jahnke Kristoph; Murillo Tulio P; Neuwelt Edward A
Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches.
Neurosurgical focus 2006;21(5):E3.
-
2006: Jahnke Kristoph; Doolittle Nancy D; Muldoon Leslie L; Neuwelt Edward A
Implications of the blood-brain barrier in primary central nervous system lymphoma.
Neurosurgical focus 2006;21(5):E11.
-
2005: Knight Kristin R Gilmer; Kraemer Dale F; Neuwelt Edward A
Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8588-96.
-
2005: Muldoon Leslie L; Sàndor Manninger; Pinkston Kristina E; Neuwelt Edward A
Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor.
Neurosurgery 2005;57(4):785-96; discussion 785-96.
-
2005: Manninger Sándor P; Muldoon Leslie L; Nesbit Gary; Murillo Tulio; Jacobs Paula M; Neuwelt Edward A
An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions.
AJNR. American journal of neuroradiology 2005;26(9):2290-300.
-
2005: Dickey D Thomas; Wu Y Jeffrey; Muldoon Leslie L; Neuwelt Edward A
Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
The Journal of pharmacology and experimental therapeutics 2005;314(3):1052-8.
-
2005: Abrey Lauren E; Batchelor Tracy T; Ferreri Andrés J M; Gospodarowicz Mary; Pulczynski Elisa J; Zucca Emanuele; Smith Justine R; Korfel Agnieszka; Soussain Carole; DeAngelis Lisa M; Neuwelt Edward A; O'Neill Brian Patrick; Thiel Eckhard; Shenkier Tamara; Graus Fransesc; van den Bent Martin; Seymour John F; Poortmans Philip; Armitage James O; Cavalli Franco;
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5034-43.
-
2005: Murillo Tulio; Neuwelt Edward
USPIOs to enhance the diagnostic potential of ultrasound in tumor and other inflammatory lesions.
AJNR. American journal of neuroradiology 2005;26(6):1305-6.
-
2005: Rosenberg Rachel I; Zirkle Dorothy L; Neuwelt Edward A
Program self-evaluation: the evolution of an injury prevention foundation.
Journal of neurosurgery 2005;102(5):847-9.
-
2005: Hunt Matthew A; Bagó Attila G; Neuwelt Edward A
Single-dose contrast agent for intraoperative MR imaging of intrinsic brain tumors by using ferumoxtran-10.
AJNR. American journal of neuroradiology 2005;26(5):1084-8.
-
2005: Shenkier Tamara N; Blay Jean-Yves; O'Neill Brian Patrick; Poortmans Philip; Thiel Eckhard; Jahnke Kristoph; Abrey Lauren E; Neuwelt Edward; Tsang Richard; Batchelor Tracy; Harris Nancy; Ferreri Andrés J M; Ponzoni Maurilio; O'Brien Peter; Rubenstein James; Connors Joseph M
Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2233-9.
-
2005: Neuwelt Edward A; Guastadisegni Paul E; Várallyay Péter; Doolittle Nancy D
Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery.
AJNR. American journal of neuroradiology 2005;26(2):258-65.
-
2005: Wu Y Jeffrey; Muldoon Leslie L; Neuwelt Edward A
The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
The Journal of pharmacology and experimental therapeutics 2005;312(2):424-31.
-
2005: Doolittle Nancy D; Abrey Lauren E; Bleyer W Archie; Brem Steven; Davis Thomas P; Dore-Duffy Paula; Drewes Lester R; Hall Walter A; Hoffman John M; Korfel Agnieszka; Martuza Robert; Muldoon Leslie L; Peereboom David; Peterson Darryl R; Rabkin Samuel D; Smith Quentin; Stevens Glen H J; Neuwelt Edward A
New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):421-8.
-
2005: Staverosky Julia A; Muldoon Leslie L; Guo Shuhua; Evans Adam J; Neuwelt Edward A; Clinton Gail M
Herstatin, an autoinhibitor of the epidermal growth factor receptor family, blocks the intracranial growth of glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):335-40.
-
2004: Neuwelt E A; Várallyay P; Bagó A G; Muldoon L L; Nesbit G; Nixon R
Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours.
Neuropathology and applied neurobiology 2004;30(5):456-71.
-
2004: Thomas Dickey D; Muldoon Leslie L; Kraemer Dale F; Neuwelt Edward A
Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.
Hearing research 2004;193(1-2):25-30.
-
2004: Neuwelt Edward A; Pagel Michael A; Kraemer Dale F; Peterson Darryl R; Muldoon Leslie L
Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model.
The Journal of pharmacology and experimental therapeutics 2004;309(2):594-9.
-
2004: Muldoon L L; Varallyay P; Kraemer D F; Kiwic G; Pinkston K; Walker-Rosenfeld S L; Neuwelt E A
Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat.
Neuropathology and applied neurobiology 2004;30(1):70-9.
-
2004: Neuwelt Edward A
Mechanisms of disease: the blood-brain barrier.
Neurosurgery 2004;54(1):131-40; discussion 141-2.
-
2003: Muldoon Leslie L; Neuwelt Edward A
BR96-DOX immunoconjugate targeting of chemotherapy in brain tumor models.
Journal of neuro-oncology 2003;65(1):49-62.
-
2003: Ferreri Andrés J M; Abrey Lauren E; Blay Jean-Yves; Borisch Bettina; Hochman Jacob; Neuwelt Edward A; Yahalom Joachim; Zucca Emanuele; Cavalli Franco; Armitage James; Batchelor Tracy
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2407-14.
-
2002: Blakley Brian W; Cohen James I; Doolittle Nancy D; Muldoon Leslie L; Campbell K C; Dickey D Thomas; Neuwelt Edward A
Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001.
The Laryngoscope 2002;112(11):1997-2001.
-
2002: Quencer Robert M; Neuwelt Edward A
Advances in the understanding of the blood-brain barrier in neuro-oncology.
AJNR. American journal of neuroradiology 2002;23(10):1807-10.
-
2002: Greene A; Barnett P; Crossen J; Sexton G; Ruzicka P; Neuwelt E
Evaluation of the THINK FIRST For KIDS injury prevention curriculum for primary students.
Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention 2002;8(3):257-8.
-
2002: Smith Justine R; Rosenbaum James T; Wilson David J; Doolittle Nancy D; Siegal Tali; Neuwelt Edward A; Pe'er Jacob
Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
Ophthalmology 2002;109(9):1709-16.
-
2002: Doolittle Nancy D; Abrey Lauren E; Ferrari Nicolay; Hall Walter A; Laws Edward R; McLendon Roger E; Muldoon Leslie L; Peereboom David; Peterson Darryl R; Reynolds C Patrick; Senter Peter; Neuwelt Edward A
Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(6):1702-9.
-
2002: Kraemer Dale F; Fortin David; Neuwelt Edward A
Chemotherapeutic dose intensification for treatment of malignant brain tumors: recent developments and future directions.
Current neurology and neuroscience reports 2002;2(3):216-24.
-
2002: Varallyay Peter; Nesbit Gary; Muldoon Leslie L; Nixon Randal R; Delashaw Johnny; Cohen James I; Petrillo Annie; Rink Doris; Neuwelt Edward A
Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
AJNR. American journal of neuroradiology 2002;23(4):510-9.
-
2001: Remsen L G; Marquez C; Garcia R; Thrun L A; Neuwelt E A
Efficacy after sequencing of brain radiotherapy and enhanced antibody targeted chemotherapy delivery in a rodent human lung cancer brain xenograft model.
International journal of radiation oncology, biology, physics 2001;51(4):1045-9.
-
2001: Neuwelt E A; Pagel M A; Hasler B P; Deloughery T G; Muldoon L L
Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
Cancer research 2001;61(21):7868-74.
-
2001: Osztie E; Várallyay P; Doolittle N D; Lacy C; Jones G; Nickolson H S; Neuwelt E A
Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
AJNR. American journal of neuroradiology 2001;22(5):818-23.
-
2001: Kraemer D F; Fortin D; Doolittle N D; Neuwelt E A
Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (human non-acquired immunodeficiency syndrome) and survival.
Neurosurgery 2001;48(5):1033-40; discussion 1040-1.
-
2001: Doolittle N D; Muldoon L L; Brummett R E; Tyson R M; Lacy C; Bubalo J S; Kraemer D F; Heinrich M C; Henry J A; Neuwelt E A
Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):493-500.
-
2001: Muldoon L L; Walker-Rosenfeld S L; Hale C; Purcell S E; Bennett L C; Neuwelt E A
Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
The Journal of pharmacology and experimental therapeutics 2001;296(3):797-805.
-
2001: Doolittle N D; Anderson C P; Bleyer W A; Cairncross J G; Cloughesy T; Eck S L; Guastadisegni P; Hall W A; Muldoon L L; Patel S J; Peereboom D; Siegal T; Neuwelt E A
Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.
Neuro-oncology 2001;3(1):46-54.
-
2000: Fortin D; McCormick C I; Remsen L G; Nixon R; Neuwelt E A
Unexpected neurotoxicity of etoposide phosphate administered in combination with other chemotherapeutic agents after blood-brain barrier modification to enhance delivery, using propofol for general anesthesia, in a rat model.
Neurosurgery 2000;47(1):199-207.
-
2000: Fortin D; Osztie E; Neuwelt E A
Iatrogenic arterial spasm relieved by intraarterial mannitol infusion.
AJNR. American journal of neuroradiology 2000;21(5):968-70.
-
2000: Remsen L G; Trail P A; Hellström I; Hellström K E; Neuwelt E A
Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model.
Neurosurgery 2000;46(3):704-9.
-
2000: Doolittle N D; Miner M E; Hall W A; Siegal T; Jerome E; Osztie E; McAllister L D; Bubalo J S; Kraemer D F; Fortin D; Nixon R; Muldoon L L; Neuwelt E A
Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.
Cancer 2000;88(3):637-47.
-
2000: Muldoon L L; Pagel M A; Kroll R A; Brummett R E; Doolittle N D; Zuhowski E G; Egorin M J; Neuwelt E A
Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):309-15.
-
2000: Guastadisegni P E; Simon J L; Neuwelt J; Camicioli R; Mueller R; Neuwelt E A
Innovative intergenerational prevention programming for older adults and adolescents.
Journal of the American Geriatrics Society 2000;48(1):105-6.
-
2000: McAllister L D; Doolittle N D; Guastadisegni P E; Kraemer D F; Lacy C A; Crossen J R; Neuwelt E A
Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.
Neurosurgery 2000;46(1):51-60; discussion 60-1.
-
1999: Fortin D; McAllister L D; Nesbit G; Doolittle N D; Miner M; Hanson E J; Neuwelt E A
Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruption in the vertebral artery.
AJNR. American journal of neuroradiology 1999;20(10):1794-802.
-
1999: Remsen L G; Pagel M A; McCormick C I; Fiamengo S A; Sexton G; Neuwelt E A
The influence of anesthetic choice, PaCO2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts.
Anesthesia and analgesia 1999;88(3):559-67.
-
1999: Neuwelt E A; Abbott N J; Drewes L; Smith Q R; Couraud P O; Chiocca E A; Audus K L; Greig N H; Doolittle N D
Cerebrovascular Biology and the various neural barriers: challenges and future directions.
Neurosurgery 1999;44(3):604-8; discussion 608-9.
-
1999: Muldoon L L; Pagel M A; Kroll R A; Roman-Goldstein S; Jones R S; Neuwelt E A
A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery.
AJNR. American journal of neuroradiology 1999;20(2):217-22.
-
1999: Lauer A K; Wobig J L; Shults W T; Neuwelt E A; Wilson M W
Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy.
American journal of ophthalmology 1999;127(2):230-3.
-
1998: Kroll R A; Pagel M A; Muldoon L L; Roman-Goldstein S; Fiamengo S A; Neuwelt E A
Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.
Neurosurgery 1998;43(4):879-86; discussion 886-9.
-
1998: Roman-Goldstein S M; Jones A; Delashaw J B; McMenomey S; Neuwelt E A
Atypical central nervous system lymphoma at the cranial base: report of four cases.
Neurosurgery 1998;43(3):613-5; discussion 615-6.
-
1998: Neuwelt E A; Brummett R E; Doolittle N D; Muldoon L L; Kroll R A; Pagel M A; Dojan R; Church V; Remsen L G; Bubalo J S
First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate.
The Journal of pharmacology and experimental therapeutics 1998;286(1):77-84.
-
1998: Neuwelt E A; Barnett P A; McCormick C I; Remsen L G; Kroll R A; Sexton G
Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(6):1549-55.
-
1998: Kroll R A; Neuwelt E A
Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.
Neurosurgery 1998;42(5):1083-99; discussion 1099-100.
-
1998: Dahlborg S A; Petrillo A; Crossen J R; Roman-Goldstein S; Doolittle N D; Fuller K H; Neuwelt E A
The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
The cancer journal from Scientific American 1998;4(2):110-24.
-
1997: Fishburne B C; Wilson D J; Rosenbaum J T; Neuwelt E A
Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
Archives of ophthalmology 1997;115(9):1152-6.
-
1997: Remsen L G; McCormick C I; Sexton G; Pearse H D; Garcia R; Mass M; Roman-Goldstein S; Neuwelt E A
Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery.
Neurosurgery 1997;40(5):1034-40; discussion 1040-2.
-
1996: Dahlborg S A; Henner W D; Crossen J R; Tableman C M; Petrillo A; Braziel R; Neuwelt E A
Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy.
The cancer journal from Scientific American 1996;2(3):166-74.
-
1996: Kroll R A; Pagel M A; Muldoon L L; Roman-Goldstein S; Neuwelt E A
Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor.
Neurosurgery 1996;38(4):746-52; discussion 752-4.
-
1996: Remsen L G; McCormick C I; Roman-Goldstein S; Nilaver G; Weissleder R; Bogdanov A; Hellström I; Kroll R A; Neuwelt E A
MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.
AJNR. American journal of neuroradiology 1996;17(3):411-8.
-
1996: Neuwelt E A; Brummett R E; Remsen L G; Kroll R A; Pagel M A; McCormick C I; Guitjens S; Muldoon L L
In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity.
Cancer research 1996;56(4):706-9.
-
1995: Muldoon L L; Nilaver G; Kroll R A; Pagel M A; Breakefield X O; Chiocca E A; Davidson B L; Weissleder R; Neuwelt E A
Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain.
The American journal of pathology 1995;147(6):1840-51.
-
1995: Nilaver G; Muldoon L L; Kroll R A; Pagel M A; Breakefield X O; Davidson B L; Neuwelt E A
Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(21):9829-33.
-
1995: Remsen L G; McCormick C I; Sexton G; Pearse H D; Garcia R; Neuwelt E A
Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(7):731-9.
-
1995: Williams P C; Henner W D; Roman-Goldstein S; Dahlborg S A; Brummett R E; Tableman M; Dana B W; Neuwelt E A
Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
Neurosurgery 1995;37(1):17-27; discussion 27-8.
-
1995: Kroll R A; Pagel M A; Roman-Goldstein S; Barkovich A J; D'Agostino A N; Neuwelt E A
White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities.
AJNR. American journal of neuroradiology 1995;16(6):1219-26.
-
1995: Doran S E; Ren X D; Betz A L; Pagel M A; Neuwelt E A; Roessler B J; Davidson B L
Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption.
Neurosurgery 1995;36(5):965-70.
-
1995: Roman-Goldstein S; Mitchell P; Crossen J R; Williams P C; Tindall A; Neuwelt E A
MR and cognitive testing of patients undergoing osmotic blood-brain barrier disruption with intraarterial chemotherapy.
AJNR. American journal of neuroradiology 1995;16(3):543-53.
-
1995: Barnett P A; Roman-Goldstein S; Ramsey F; McCormick C I; Sexton G; Szumowski J; Neuwelt E A
Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat.
The American journal of pathology 1995;146(2):436-49.
-
1994: Kroll R A; Pagel M A; Langone J J; Sexton G J; Neuwelt E A
Differential permeability of the blood-tumour barrier in intracerebral tumour-bearing rats: antidrug antibody to achieve systemic drug rescue.
Therapeutic immunology 1994;1(6):333-41.
-
1994: Neuwelt E A; Barnett P A; Hellström K E; Hellström I; McCormick C I; Ramsey F L
Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(11):1831-41.
-
1994: Roman-Goldstein S M; Barnett P A; McCormick C I; Szumowski J; Shannon E M; Ramsey F L; Mass M; Neuwelt E A
Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings.
Journal of computer assisted tomography 1994;18(5):731-6.
-
1994: Muldoon L L; Neuwelt E A; Pagel M A; Weiss D L
Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease).
The American journal of pathology 1994;144(5):1109-18.
-
1994: Neuwelt E A; Weissleder R; Nilaver G; Kroll R A; Roman-Goldstein S; Szumowski J; Pagel M A; Jones R S; Remsen L G; McCormick C I
Delivery of virus-sized iron oxide particles to rodent CNS neurons.
Neurosurgery 1994;34(4):777-84.
-
1994: Roman-Goldstein S; Clunie D A; Stevens J; Hogan R; Monard J; Ramsey F; Neuwelt E A
Osmotic blood-brain barrier disruption: CT and radionuclide imaging.
AJNR. American journal of neuroradiology 1994;15(3):581-90.
-
1994: Crossen J R; Garwood D; Glatstein E; Neuwelt E A
Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):627-42.
-
1994: Neuwelt E A; Wiliams P C; Mickey B E; Frenkel E P; Henner W D
Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption.
Pediatric neurosurgery 1994;21(1):16-22.
-
1993: Neuwelt E A; Barnett P A; Ramsey F L; Hellström I; Hellström K E; McCormick C I
Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenografts.
Neurosurgery 1993;33(3):478-84; discussion 484.
-
1993: Williams J A; Roman-Goldstein S; Crossen J R; D'Agostino A; Dahlborg S A; Neuwelt E A
Preirradiation osmotic blood-brain barrier disruption plus combination chemotherapy in gliomas: quantitation of tumor response to assess chemosensitivity.
Advances in experimental medicine and biology 1993;331():273-84.
-
1993: Gumerlock M K; Neuwelt E A
Primary cerebral lymphoma.
Cancer treatment and research 1993;66():111-26.
-
1992: Nazzaro J M; Pagel M A; Neuwelt E A
Further refinement of the Escherichia coli brain abscess model in rat.
Journal of neuroscience methods 1992;44(2-3):85-90.
-
1992: Avolio A E; Ramsey F L; Neuwelt E A
Evaluation of a program to prevent head and spinal cord injuries: a comparison between middle school and high school.
Neurosurgery 1992;31(3):557-61; discussion 561-2.
-
1992: Roman-Goldstein S M; Goldman D L; Howieson J; Belkin R; Neuwelt E A
MR of primary CNS lymphoma in immunologically normal patients.
AJNR. American journal of neuroradiology 1992;13(4):1207-13.
-
1992: Nazzaro J M; Shults W T; Neuwelt E A
Neuro-ophthalmological function of patients with pineal region tumors approached transtentorially in the semisitting position.
Journal of neurosurgery 1992;76(5):746-51.
-
1992: Crossen J R; Goldman D L; Dahlborg S A; Neuwelt E A
Neuropsychological assessment outcomes of nonacquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy.
Neurosurgery 1992;30(1):23-9.
-
1991: Roman-Goldstein S M; Barnett P A; McCormick C I; Ball M J; Ramsey F; Neuwelt E A
Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings.
AJNR. American journal of neuroradiology 1991;12(5):885-90.
-
1991: Neuwelt E A; Goldman D L; Dahlborg S A; Crossen J; Ramsey F; Roman-Goldstein S; Braziel R; Dana B
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1580-90.
-
1991: Nazzaro J M; Rosenbaum L C; Pagel M A; Neuwelt E A
A new model of systemic drug rescue based on permeability characteristics of the blood-brain barrier in intracerebral abscess-bearing rats.
Journal of neurosurgery 1991;74(3):467-74.
-
1991: Neuwelt E A; Pagel M A; Dix R D
Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier.
Journal of neurosurgery 1991;74(3):475-9.
-
1990: Rosenbaum L C; Neuwelt E A; Van Tol H H; Loh Y P; Verbalis J G; Hellström I; Hellström K E; Nilaver G
Expression of neurophysin-related precursor in cell membranes of a small-cell lung carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(24):9928-32.
-
1990: Nilaver G; Rosenbaum L C; Van Tol H H; Shannon E M; Hagman H M; Zimmerman E A; Neuwelt E A
Immunological studies with a monoclonal antibody suggest a different conformation of neurophysin in parvicellular neurons of rat hypothalamus.
Brain research 1990;529(1-2):302-8.
-
1990: Nazzaro J M; Neuwelt E A
The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults.
Journal of neurosurgery 1990;73(3):331-44.
-
1990: Nilaver G; Rosenbaum L C; Hellström K E; Hellström I; Neuwelt E A
Identification of neurophysin immunoreactivity in hypothalamus by a monoclonal antibody to a carcinoma cell surface antigen.
Neuroendocrinology 1990;51(5):565-71.
-
1990: Gumerlock M K; Neuwelt E A
The effects of anesthesia on osmotic blood-brain barrier disruption.
Neurosurgery 1990;26(2):268-77.
-
1990: Neuwelt E A; Horaczek A; Pagel M A
The effect of steroids on gentamicin delivery to brain after blood-brain barrier disruption.
Journal of neurosurgery 1990;72(1):123-6.
-
1990: Neuwelt E A; Nazzaro J M; Gumerlock M K
Is there a role for biopsy in the treatment of supratentorial high-grade glioma?
Clinical neurosurgery 1990;36():384-407.
-
1989: Rosenbaum L C; Nilaver G; Hagman H M; Neuwelt E A
Detection of low-molecular-weight polypeptides on nitrocellulose with monoclonal antibodies.
Analytical biochemistry 1989;183(2):250-7.
-
1989: Yeager R A; Moneta G L; McConnell D B; Neuwelt E A; Taylor L M; Porter J M
Analysis of risk factors for myocardial infarction following carotid endarterectomy.
Archives of surgery (Chicago, Ill. : 1960) 1989;124(10):1142-5.
-
1989: Neuwelt E A
Radiotherapy for tumours of the pineal region and suprasellar germinomas (by Glanzmann and Seelentag)
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1989;16(1):79-80.
-
1989: Nilaver G; Rosenbaum L C; Fukui K; Neuwelt E A; Samson W K; Zimmerman E A; Gibbs D M
An antiserum to atrial natriuretic factor (ANF) cross-reacts with neurophysins in the hypothalamo-neurohypophysial system of rat brain.
Neuropeptides 1989;14(2):137-44.
-
1989: Neuwelt E A; Coe M F; Wilkinson A M; Avolio A E
Oregon Head and Spinal Cord Injury Prevention Program and evaluation.
Neurosurgery 1989;24(3):453-8.
-
1988: Gumerlock M K; Neuwelt E A
Carotid endarterectomy: to shunt or not to shunt.
Stroke; a journal of cerebral circulation 1988;19(12):1485-90.
-
1988: Neuwelt E A; Barnett P A; Hellström I; Hellström K E; Beaumier P; McCormick C I; Weigel R M
Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption.
Cancer research 1988;48(17):4725-9.
-
1987: Goldstein S; Gumerlock M K; Neuwelt E A
Comparison of CT-guided and stereotaxic cranial diagnostic needle biopsies.
Journal of neurosurgery 1987;67(3):341-8.
-
1987: Neuwelt E A; Specht H D; Barnett P A; Dahlborg S A; Miley A; Larson S M; Brown P; Eckerman K F; Hellström K E; Hellström I
Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system.
Neurosurgery 1987;20(6):885-95.
-
1987: Goldstein S; Neuwelt E A
Superior sensitivity of computed tomographic scanning to magnetic resonance imaging in metastatic neoplasia: two case reports.
Neurosurgery 1987;20(6):959-62.
-
1987: Neuwelt E A; Dahlborg S A
Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases.
Journal of neuro-oncology 1987;4(3):195-207.
-
1986: Millay R H; Klein M L; Shults W T; Dahlborg S A; Neuwelt E A
Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier.
American journal of ophthalmology 1986;102(5):626-32.
-
1986: Neuwelt E A; Frenkel E P; Gumerlock M K; Braziel R; Dana B; Hill S A
Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective series.
Cancer 1986;58(8):1609-20.
-
1986: Neuwelt E A; Howieson J; Frenkel E P; Specht H D; Weigel R; Buchan C G; Hill S A
Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.
Neurosurgery 1986;19(4):573-82.
-
1986: Neuwelt E A; Specht H D; Hill S A
Permeability of human brain tumor to 99mTc-gluco-heptonate and 99mTc-albumin. Implications for monoclonal antibody therapy.
Journal of neurosurgery 1986;65(2):194-8.
-
1986: Neuwelt E A; Minna J; Frenkel E; Barnett P A; McCormick C I
Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat.
The American journal of physiology 1986;250(5 Pt 2):R875-83.
-
1986: Neuwelt E A; Mickey B; Lewy A J
The importance of melatonin and tumor markers in pineal tumors.
Journal of neural transmission. Supplementum 1986;21():397-413.
-
1985: Neuwelt E A; Barnett P A; McCormick C I; Frenkel E P; Minna J D
Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain.
Neurosurgery 1985;17(3):419-23.
-
1985: Neuwelt E A; Johnson W G; Blank N K; Pagel M A; Maslen-McClure C; McClure M J; Wu P M
Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats.
The Journal of clinical investigation 1985;76(2):482-90.
-
1985: Neuwelt E A; Frenkel E P; D'Agostino A N; Carney D N; Minna J D; Barnett P A; McCormick C I
Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.
Cancer research 1985;45(6):2827-33.
-
1985: Gumerlock M K; Coull B M; Howieson J; Buchan C; Neuwelt E A
Late stenosis of a superficial temporal-middle cerebral artery bypass: angiographic and histological findings.
Neurosurgery 1985;16(5):650-7.
-
1985: Neuwelt E A; Buchan C; Blank N K; Lewy A J
Surgical resection of a pineal tumor containing elements of germinoma and astrocytoma.
Neurosurgery 1985;16(3):373-8.
-
1985: Ohata M; Fredericks W R; Neuwelt E A; Sundaram U; Rapoport S I
[3H]Methotrexate loss from the rat brain following enhanced uptake by osmotic opening of the blood-brain barrier.
Cancer research 1985;45(3):1092-6.
-
1985: Neuwelt E A
An update on the surgical treatment of malignant pineal region tumors.
Clinical neurosurgery 1985;32():397-428.
-
1984: Kikuchi K; McCormick C I; Neuwelt E A
Immunosuppression by phenytoin: implication for altered immune competence in brain-tumor patients.
Journal of neurosurgery 1984;61(6):1085-90.
-
1984: Neuwelt E A; Lawrence M S; Blank N K
Effect of gentamicin and dexamethasone on the natural history of the rat Escherichia coli brain abscess model with histopathological correlation.
Neurosurgery 1984;15(4):475-83.
-
1984: Neuwelt E A; Baker D E; Pagel M A; Blank N K
Cerebrovascular permeability and delivery of gentamicin to normal brain and experimental brain abscess in rats.
Journal of neurosurgery 1984;61(3):430-9.
-
1984: Neuwelt E A; Hill S A; Frenkel E P
Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening.
Neurosurgery 1984;15(3):362-6.
-
1984: Neuwelt E A; Barranger J A; Pagel M A; Quirk J M; Brady R O; Frenkel E P
Delivery of active hexosaminidase across the blood-brain barrier in rats.
Neurology 1984;34(8):1012-9.
-
1984: Neuwelt E A; Rapoport S I
Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
Federation proceedings 1984;43(2):214-9.
-
1984: Neuwelt E A; Barnett P A; Frenkel E P
Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery.
Neurosurgery 1984;14(2):154-60.
-
1984: Neuwelt E A
Therapeutic potential for blood-brain barrier modification in malignant brain tumor.
Progress in experimental tumor research. Fortschritte der experimentellen Tumorforschung. Progrès de la recherche expérimentale des tumeurs 1984;28():51-66.
-
1983: Kikuchi K; Neuwelt E A
Presence of immunosuppressive factors in brain-tumor cyst fluid.
Journal of neurosurgery 1983;59(5):790-9.
-
1983: Neuwelt E A; Barnett P A; Glasberg M; Frenkel E P
Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification.
Cancer research 1983;43(11):5278-85.
-
1983: Neuwelt E A; Specht H D; Howieson J; Haines J E; Bennett M J; Hill S A; Frenkel E P
Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning.
AJR. American journal of roentgenology 1983;141(4):829-35.
-
1983: Neuwelt E A; Glasberg M; Frenkel E; Barnett P
Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies.
Annals of neurology 1983;14(3):316-24.
-
1983: Neuwelt E A; Balaban E; Diehl J; Hill S; Frenkel E
Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening.
Neurosurgery 1983;12(6):662-71.
-
1983: Neuwelt E A; Lewy A J
Disappearance of plasma melatonin after removal of a neoplastic pineal gland.
The New England journal of medicine 1983;308(19):1132-5.
-
1983: Gumerlock M K; Ono H; Neuwelt E A
Can a patent extracranial-intracranial bypass provoke the conversion of an intracranial arterial stenosis to a symptomatic occlusion?
Neurosurgery 1983;12(4):391-400.
-
1983: Neuwelt E A; Kikuchi K; Hill S; Lipsky P; Frenkel E P
Immune responses in patients with brain tumors. Factors such as anti-convulsants that may contribute to impaired cell-mediated immunity.
Cancer 1983;51(2):248-55.
-
1983: Neuwelt E A; Hill S A; Kikuchi K
Malignant and benign brain tumors: current concepts and intervention.
Comprehensive therapy 1983;9(1):24-32.
-
1983: Neuwelt E A; Barnett P; Barranger J; McCormick C; Pagel M; Frenkel E
Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier.
Neurosurgery 1983;12(1):29-34.
-
1982: Kandalaft N; Diehl J; Neuwelt E A
Nonneoplastic intracranial lesions simulating neoplasms on computed tomographic scan. Excellent sensitivity with limited specificity.
JAMA : the journal of the American Medical Association 1982;248(17):2166-8.
-
1982: Neuwelt E A; Barnett P A; Bigner D D; Frenkel E P
Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(14):4420-3.
-
1982: Hill S A; Neuwelt E A
Intra-arterial chemotherapy following blood-brain barrier disruption in a patient with malignant glioma.
Journal of neurosurgical nursing 1982;14(2):94-7.
-
1982: Watson S W; Sinn D P; Neuwelt E A
Dental considerations in the sublabial trans-sphenoidal surgical approach to the pituitary gland.
Neurosurgery 1982;10(2):236-41.
-
1982: Neuwelt E A; Kikuchi K; Hill S A; Lipsky P; Frenkel E
Barbiturate inhibition of lymphocyte function. Differing effects of various barbiturates used to induce coma.
Journal of neurosurgery 1982;56(2):254-9.
-
1981: Neuwelt E A; Glasberg M; Diehl J; Frenkel E P; Barnett P
Osmotic blood-brain barrier disruption in the posterior fossa of the dog.
Journal of neurosurgery 1981;55(5):742-8.
-
1981: Neuwelt E A; Pagel M; Barnett P; Glassberg M; Frenkel E P
Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification.
Cancer research 1981;41(11 Pt 1):4466-70.
-
1981: Neuwelt E A; Barranger J A; Brady R O; Pagel M; Furbish F S; Quirk J M; Mook G E; Frenkel E
Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood--brain barrier.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(9):5838-41.
-
1981: Neuwelt E A; Diehl J T; Vu L H; Hill S A; Michael A J; Frenkel E P
Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.
Annals of internal medicine 1981;94(4 pt 1):449-54.
-
1981: Neuwelt E A
CT monitoring of chemotherapeutic agent delivery after osmotic blood brain barrier disruption.
Clinical neurosurgery 1981;28():520-31.
-
1981: Neuwelt E A; Hill S A; Frenkel E P; Diehl J T; Maravilla K R; Vu L H; Clark W K; Rapoport S I; Barnett P A; Lewis S E; Ehle A L; Beyer C W
Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
Cancer treatment reports 1981;65 Suppl 2():39-43.
-
1981: Neuwelt E A
Use of antibodies and the primary enzyme immunoassay (PEIA) to study enzymes: the arylsulfatase A--anti-arylsulfatase A system.
Methods in enzymology 1981;73(Pt B):550-78.
-
1980: Neuwelt E A; Frenkel E P; Smith R G
Suprasellar germinomas (ectopic pinealomas): aspects of immunological characterization and successful chemotherapeutic responses in recurrent disease.
Neurosurgery 1980;7(4):352-8.
-
1980: Neuwelt E A
Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.
Neurosurgery 1980;7(2):204.
-
1980: Neuwelt E A; Frenkel E P; Rapoport S; Barnett P
Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog.
Neurosurgery 1980;7(1):36-43.
-
1980: Neuwelt E A; Frenkel E P
Is there a therapeutic role for blood-brain barrier disruption?
Annals of internal medicine 1980;93(1):137-9.
-
1980: Neuwelt E A; Frenkel E P; Diehl J; Vu L H; Rapoport S; Hill S
Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.
Neurosurgery 1980;7(1):44-52.
-
1980: Samson D S; Neuwelt E A; Beyer C W; Ditmore Q M
Failure of extracranial-intracranial arterial bypass in acute middle cerebral artery occlusion: case report.
Neurosurgery 1980;6(2):185-8.
-
1980: Neuwelt E A; Maravilla K R; Frenkel E P; Barnett P; Hill S; Moore R J
Use of enhanced computerized tomography to evaluate osmotic blood-brain barrier disruption.
Neurosurgery 1980;6(1):49-56.
-
1979: Neuwelt E A; Glasberg M; Frenkel E; Clark W K
Malignant pineal region tumors. A clinico-pathological study.
Journal of neurosurgery 1979;51(5):597-607.
-
1979: Neuwelt E A; Diehl J T; Hill S A; Maravilla K R
Use of metrizamide computerized tomographic cisternography in the evaluation of patients with malignant glioma for immunotherapy.
Neurosurgery 1979;5(5):576-82.
-
1979: Maravilla K R; Neuwelt E A; Diehl J T
Application of metrizamide in the radiographic evaluation of the neurologically diseased patient.
Neurosurgery 1979;5(3):389-406.
-
1979: Neuwelt E A; Maravilla K R; Frenkel E P; Rapaport S I; Hill S A; Barnett P A
Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery.
The Journal of clinical investigation 1979;64(2):684-8.
-
1979: Neuwelt E A; Smith R G
Presence of lymphocyte membrane surface markers on "small cells" in a pineal germinoma.
Annals of neurology 1979;6(2):133-6.
-
1979: Neuwelt E A; Frenkel E P; Diehl J T; Maravilla K R; Vu L H; Clark W K; Rapoport S I; Barnett P A; Hill S A; Lewis S E; Ehle A L; Beyer C W; Moore R J
Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent delivery.
Transactions of the American Neurological Association 1979;104():256-60.
-
1978: Neuwelt E A; Clark W K
Unique aspects of central nervous system immunology.
Neurosurgery 1978;3(3):419-30.
-
1978: Neuwelt E A; Clark K; Kirkpatrick J B; Toben H
Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant glioma: a toxicity study.
Annals of neurology 1978;4(4):307-12.
-
1978: Neuwelt E A; Garcia J H; Mena H
Diffuse microglial proliferation after global ischemia in a patient with aplastic bone marrow.
Acta neuropathologica 1978;43(3):259-62.
-
1978: Neuwelt E A; Boguski M S; Frank J J; Procter-Appich K; Levy C C
Possible sites of origin of human plasma ribonucleases as evidenced by isolation and partial characterization of ribonucleases from several human tissues.
Cancer research 1978;38(1):88-93.
-
1977: Neuwelt E; Doherty D
Toxicity kinetics and clinical potential of subarachnoid lymphocyte infusions.
Journal of neurosurgery 1977;47(2):205-17.
-
1977: Neuwelt E A; Garcia J H; Kolar O; Rao K; Ducker T
Elevated CSF gamma globulins with cerebral "glioma.".
Surgical neurology 1977;8(2):107-10.
-
1977: Humphrey R L; Karpetsky T P; Neuwelt E A; Levy C C
Levels of serum ribonuclease as an indicator of renal insufficiency in patients with leukemia.
Cancer research 1977;37(7 Pt 1):2015-22.
-
1977: Neuwelt E A; Schmukler M; Niziak M S; Jewett P B; Levy C C
The immunological characterization of several human ribonucleases by using primary binding tests.
The Biochemical journal 1977;163(3):419-26.
-
1977: Rosenberg R N; Neuwelt E A; Kirkpatrick J; Kohler P
Encephalopathy associated with cryoprecipitable Australia antigen.
Annals of neurology 1977;1(3):298-300.
-
1976: Neuwelt E A; Gahl W A; Levy C C
Immunological studies on the interaction of polyadenylic acid and human liver ribonuclease.
Biochemical and biophysical research communications 1976;73(4):885-93.
-
1976: Neuwelt E A; Frank J J; Levy C C
Purification of human spleen ribonuclease by immunoabsorption. Similarity of the enzyme with human liver ribonuclease.
The Journal of biological chemistry 1976;251(18):5752-8.
-
1973: Neuwelt E; Kohler P F; Austin J
Primary enzyme immunoassay (PEIA): studies of the mutant enzyme in metachromatic leukodystrophy (primary enzyme immunoassay of arylsulfatase-A).
Immunochemistry 1973;10(11):767-73.
-
1971: Stumpf D; Neuwelt E; Austin J; Kohler P
Metachromatic leukodystrophy (MLD). X. Immunological studies of the abnormal sulfatase A.
Archives of neurology 1971;25(5):427-31.
-
1971: Neuwelt E; Stumpf D; Austin J; Kohler P
A monospecific antibody to human sulfatase A. Preparation, characterization and significance.
Biochimica et biophysica acta 1971;236(1):333-46.
-
1971: Stumpf D; Neuwelt E; Austin J; Kohler P
Immunological studies of sulfatase A in normals and in metachromatic leukodystrophy.
Transactions of the American Neurological Association 1971;96():80-3.
Sign-in to see more
